View the HEPBEST registration information details.
Back to drug list
ItemsDrug Registration information
ID505
No505
Brand NameHEPBEST
IngredientsTENOFOVIR ALAFENAMIDE FUMARATE IH 28.043 MG EQ.TO TENOFOVIR ALAFENAMIDE 25 MG
Dosage FormFILM COATED TABLET
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 30 TABLETS/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR THE TREATMENT OF CHRONIC HEPATITIS B VIRUS INFECTION IN ADULTS WITH COMPENSATED LIVER DISEASE
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE TO OFF WHITE, FILM COATED, ROUND, BICONVEX TABLET DEBOSSED WITH M ON ONE SIDE OF THE TABLET AND TFI ON THE OTHER SIDE
Note
License OwnerDKSH LAOS COMPANY LIMITED
ManufacturerMYLAN LABORATORIES LIMITED
CountryINDIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No12 I 5342/22
FDD Registration Date30/12/2022
Expiry Date29/12/2025
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA